Inventor · disambiguated record
Anthony Beauglehole
Also filed as: BEAUGLEHOLE ANTHONY · BEAUGLEHOLE ANTHONY R
10 granted patents·6 pending applications·69 citations·filing 2005–2017
87Inventor score
Files withLEWIS AND CLARK PHARMACEUTICALS INC4BEAUGLEHOLE ANTHONY3ADENOSINE THERAPEUTICS LLC2THOMPSON ROBERT D2BEAUGLEHOLE ANTHONY R1
Top patents by PatentIndex Score
16 records- 0192US9067963B2N-alkyl 2-(disubstituted)alkynyladenosine-5-uronamides as A2A agonistsLEWIS AND CLARK PHARMACEUTICALS INC·Filed 2013·Granted Jun 30, 2015·30 cites·32 claims
- 0287US7217702B2Selective antagonists of A2A adenosine receptorsADENOSINE THERAPEUTICS LLC·Filed 2005·Granted May 15, 2007·12 cites·86 claims
- 0385US7875608B2Substituted 8-[6-amino-3pyridyl]xanthinesTHOMPSON ROBERT D·Filed 2008·Granted Jan 25, 2011·9 cites·24 claims
- 0482US8058259B2Substituted 4-{3-[6-amino-9-(3,4-dihydroxy-tetrahydro-furan-2-yl)-9H-purin-2-yl]-prop-2-ynyl}-piperidine-1-carboxylic acid esters as A2AR agonistsTHOMPSON ROBERT DOUGLAS·Filed 2008·Granted Nov 15, 2011·10 cites·19 claims
- 0575US8293720B2Substituted 4-{3-[6-amino-9-(3, 4-dihydroxy-tetrahydro-furan-2-yl)-9H-purin-2-yl]-prop-2-ynyl}-piperidine-1-carboxylic acid esters as A2AR agonistsTHOMPSON ROBERT D·Filed 2008·Granted Oct 23, 2012·2 cites·30 claims
- 0675US8252767B2Substituted 4-{3-[6-amino-9-(3, 4-dihydroxy-tetrahydro-furan-2-yl)-9H-purin-2-yl]-prop-2-ynyl}-piperidine-1-carboxylic acid esters as A2AR agonistsTHOMPSON ROBERT·Filed 2008·Granted Aug 28, 2012·2 cites·25 claims
- 0769US9822141B2N-alkyl 2-(disubstituted)alkynyladenosine-5-uronamides as A2A agonistsLEWIS AND CLARK PHARMACEUTICALS INC·Filed 2015·Granted Nov 21, 2017·1 cites·28 claims
- 0866US7985754B2Selective antagonists of A2A adenosine receptorsTROVIS PHARMACEUTICALS LLC·Filed 2007·Granted Jul 26, 2011·1 cites·19 claims
- 0964US8263762B2Alkoxy-carbonyl-amino-alkynyl-adenosine compounds and derivatives thereof as A2AR agonistsBEAUGLEHOLE ANTHONY R·Filed 2010·Granted Sep 11, 2012·2 cites·33 claims
- 1060US2009181920A1Intrathecal treatment of neuropathic pain with a2ar agonistsPGXHEALTH LLC·Filed 2009·Application pending·0 cites
- 1159US2008176858A1Selective antagonists of a2a adenosine receptorsADENOSINE THERAPEUTICS LLC·Filed 2008·Application pending·0 cites
- 1258US2007244134A1Selective antagonists of A2A adenosine receptorsBEAUGLEHOLE ANTHONY·Filed 2007·Application pending·0 cites
- 1353US2012309774A1Selective antagonists of a2a adenosine receptorsBEAUGLEHOLE ANTHONY·Filed 2012·Application pending·0 cites
- 1451US2012035192A1Selective antagonists of a2a adenosine receptorsBEAUGLEHOLE ANTHONY·Filed 2011·Application pending·0 cites
- 1550US2019077824A1N-alkyl 2-(disubstituted)alkynyladenosine-5-uronamides as a2a agonistsLEWIS AND CLARK PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
- 1640US9593118B2Xanthine-substituted alkynyl carbamates/reverse carbamates as A2B antagonistsLEWIS AND CLARK PHARMACEUTICALS INC·Filed 2016·Granted Mar 14, 2017·0 cites·21 claims
Join the waitlist — get patent alerts
Get an alert when Anthony Beauglehole files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →